Furthermore, we identified novel regulatory circuits involving miR-148a-3p/ERBB3/AKT2/c-myc and DNA methyltransferase 1 (DNMT1) in the control of bladder cancer progression. This evidence concerns the gene AKT2 and urinary bladder cancer.